Volume 28, Number 5—May 2022
Pathogens that Cause Illness Clinically Indistinguishable from Lassa Fever, Nigeria, 2018
|Sample||TAC hits||Seq hit 1 (no. mapped reads)||Seq hit 2 (no. mapped reads)||Seq hit 3 (no. mapped reads)||Seq hit 4 (no. mapped reads)||Seq hit 5 (no. mapped reads)|
|307||Klebsiella pneumoniae||Salmonella_hilA (108)||Salmonella_ttr (55)||Enterobacter (55)||Enterobacter cloacae (55)||Enterobacter (56)|
|349||Escherichia coli generic||E. coli (58)||None||None||None||None|
|344||Streptococcus||Mec_A (591)||Staphylococcus (657)||Pseudomonas aeruginosa (3)||Streptococcus. pyogenes (591)||Streptococcus (591)|
- McCormick JB, King IJ, Webb PA, Johnson KM, O’Sullivan R, Smith ES, et al. A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis. 1987;155:445–55.
- Marongiu L, Shain E, Drumright L, Lillestøl R, Somasunderam D, Curran MD. Analysis of TaqMan Array Cards data by an assumption-free improvement of the maxRatio algorithm is more accurate than the cycle-threshold method. PLoS One. 2016;11:
- Wood DE, Lu J, Langmead B. Improved metagenomic analysis with Kraken 2. Genome Biol. 2019;20:257.
- Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics. 2010;26:589–95.
- Kafetzopoulou LE, Pullan ST, Lemey P, Suchard MA, Ehichioya DU, Pahlmann M, et al. Metagenomic sequencing at the epicenter of the Nigeria 2018 Lassa fever outbreak. Science. 2019;363:74–7.
- Lewandowski K, Xu Y, Pullan ST, Lumley SF, Foster D, Sanderson N, et al. Metagenomic nanopore sequencing of influenza virus direct from clinical respiratory samples. J Clin Microbiol. 2019;58:e00963–19.
- Shields A, Patel S. Infections in the immunocompromised host: primary immunodeficiency disorders. Medicine (Baltimore). 2021;49:603–10.
- Nigeria Centre for Disease Control. An update of yellow fever outbreak in Nigeria [cited 2021 May 1]. https://ncdc.gov.ng/diseases/sitreps/?cat=10&name=An%20update%20of%20Yellow%20Fever%20outbreak%20in%20Nigeria
1Current affiliation: Army, Defence Science & Technology, Ministry of Defence, London, UK.
Page created: February 25, 2022
Page updated: April 19, 2022
Page reviewed: April 19, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.